about
Monocytes in atherosclerosis: subsets and functionsNear Infrared Fluorescence (NIRF) Molecular Imaging of Oxidized LDL with an Autoantibody in Experimental Atherosclerosis.Erythrocyte hemolysis and hemoglobin oxidation promote ferric chloride-induced vascular injuryLangerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC networkImaging leukocyte adhesion to the vascular endothelium at high intraluminal pressure.A proteomic analysis of C-reactive protein stimulated THP-1 monocytesPARP-14 combines with tristetraprolin in the selective posttranscriptional control of macrophage tissue factor expression.Raised soluble P-selectin moderately accelerates atherosclerotic plaque progressionSoluble bio-markers in vascular disease: much more than gauges of disease?Triglyceride-Rich Lipoproteins Modulate the Distribution and Extravasation of Ly6C/Gr1(low) Monocytes.Therapeutic targeting of p-selectin in atherosclerosis.New Wistar Kyoto and spontaneously hypertensive rat transgenic models with ubiquitous expression of green fluorescent proteinThe anti inflammatory effects of high density lipoproteins.Integrin CD11b positively regulates TLR4-induced signalling pathways in dendritic cells but not in macrophagesHigh-density lipoprotein: a potent inhibitor of inflammation.P-selectin antagonism in inflammatory disease.Targeting monocyte and macrophage subpopulations for immunotherapy: a patent review (2009 - 2013).Effects of dyslipidaemia on monocyte production and function in cardiovascular disease.Very-low and low-density lipoproteins induce neutral lipid accumulation and impair migration in monocyte subsets.C-reactive protein mediates CD11b expression in monocytes through the non-receptor tyrosine kinase, Syk, and calcium mobilization but not through cytosolic peroxides.The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species.Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors.Effects of oral vitamin C on monocyte: endothelial cell adhesion in healthy subjects.Vitamin C supplementation in normal subjects reduces constitutive ICAM-1 expression.Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes.Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque.High-density lipoprotein reduces the human monocyte inflammatory response.Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules.Gravity spun polycaprolactone fibers for applications in vascular tissue engineering: proliferation and function of human vascular endothelial cells.The Endless Summer: Thermoneutrality Prevents Monocytosis and Reduces Atherosclerosis.A triglyceride-rich lipoprotein environment exacerbates renal injury in the accelerated nephrotoxic nephritis model.Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy.MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure.AtherosclerosisCD14 expression is increased on monocytes in patients with anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis and correlates with the expression of ANCA autoantigensLower Apo A-I and Lower HDL-C Levels Are Associated With Higher Intermediate CD14 ++ CD16 + Monocyte Counts That Predict Cardiovascular Events in Chronic Kidney DiseaseThe heterogeneous mononuclear phagocyte system of the kidneyImmunological aspects of atherosclerosis: Figure 1Neutrophil Activation Is Attenuated by High-Density Lipoprotein and Apolipoprotein A-I in In Vitro and In Vivo Models of InflammationDissociation of Pentameric to Monomeric C-Reactive Protein on Activated Platelets Localizes Inflammation to Atherosclerotic Plaques
P50
Q22251045-ADF2DAAA-7D02-41A3-8CC7-8F595C3EB37FQ27343116-99B10D53-EA97-4D34-884A-DDFD97FCA8A3Q30487336-EB75F729-860F-4347-B9F1-7AA650E600DBQ33590503-AFE40444-BA39-4CD5-8B59-F9FFA50EA919Q34005210-D90ED44A-DE98-496C-AD3B-7C7F74D30131Q34504081-4FA26F32-0220-4C89-ADDE-51D3C6D48C1DQ34636901-D69B91B7-248C-4E0D-B783-67C26C11A551Q35171696-5CC9C24C-1A5E-4AA8-91E2-898BC1A1E420Q36089375-CEF32F9E-3AF9-4BF7-BDA0-256C1CB37E17Q36111469-97336D8C-6DD9-498E-B4D7-798C83421DCCQ36757689-363AD0F7-485C-4F89-AC35-B9F722F8673DQ36856042-B192FC23-08F3-490E-BB9A-9BE714B4174DQ37387422-20854F04-ECB6-4409-B64B-D8670AEDC6C0Q37528466-3716A4EA-0BC4-46EA-96D4-3257AA95AC7FQ37636513-516D6B32-0F57-4576-854E-078293B53822Q37830079-3269292A-58E8-4F11-BBAD-9DB3BD681DEBQ38207732-C90AF585-E264-4B88-BFEB-BDB46961A1A1Q38903993-014B85EC-159E-45B6-BA2B-4E4027D2CA3FQ40048017-23C03F82-159E-401C-8EC8-1417CBE69E8CQ40334569-096842BD-AFF2-4EAB-8218-3619686E4A17Q41978298-769BF783-60B2-4151-A575-7641BCFF4721Q42101285-82959098-2987-45CC-B6F8-7E62DCF46EFCQ44034973-5B309AA3-8B41-44AF-8BB5-AF2F4A651512Q44539001-02A1DFFE-B9C0-4632-9E6C-4BC59C2FAF4CQ46103013-B1AF63F8-F298-4EC7-A31B-F04FE6D6C2A5Q46333846-3A91D22A-61B4-4144-98FB-748489B229A3Q46490309-EEEB658F-3AB6-45CD-BFC2-C5BD77E6258CQ46841200-6AF06D37-1D38-4BCC-9035-AD8736FFDBD9Q46961720-BF50CFFD-7EDC-4CF6-9C66-766E7E13BCA8Q47873926-08AA5D00-F345-4F45-B15F-B3CC45B51BEEQ48100272-87664D8D-A60C-4975-9CFB-E6902DBC6A38Q51070812-06924212-D8ED-4097-AFE9-2584A7363316Q52774474-34E64CEA-C39D-4218-98B3-6F56B75D6F85Q57132044-20243828-28A9-414F-959E-F90C0821CBA9Q57132096-D80BDECF-863F-4E3F-BB94-0331F66561F9Q57132129-A7F88529-65C6-41BD-A17B-1A4FBE7CC92FQ57132216-C50AF0F7-07C1-420F-BAA4-9C9284D6B1B6Q57132246-9327FFBF-6842-4AF8-9779-AB3895020E7BQ57132293-E8359A4F-555C-47E3-8616-C6C2B6AB457EQ57132361-F008C037-A1E6-4DE6-8E19-9C6FD043C0D9
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Kevin J Woollard
@ast
Kevin J Woollard
@en
Kevin J Woollard
@es
Kevin J Woollard
@nl
Kevin J Woollard
@sl
type
label
Kevin J Woollard
@ast
Kevin J Woollard
@en
Kevin J Woollard
@es
Kevin J Woollard
@nl
Kevin J Woollard
@sl
prefLabel
Kevin J Woollard
@ast
Kevin J Woollard
@en
Kevin J Woollard
@es
Kevin J Woollard
@nl
Kevin J Woollard
@sl
P108
P106
P21
P2798
P31
P3835
kevin-woollard
P496
0000-0002-9839-5463